Companies › ADMA

ADMA BIOLOGICS (ADMA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001368514 · EDGAR filings · Updated 2026-07-28

ADMA BIOLOGICS (ADMA) has reported institutional ownership of 91.4%, with 356 institutional managers holding positions valued at $1.91B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-06-02 — Current report (8-K) filed
• 2026-05-28 — Insider transaction reported (Form 4)
• 2026-05-14 — Insider transaction reported (Form 4)
• 2026-05-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ADMA BIOLOGICS has 356 institutional holders and institutional ownership of 91.4%.

Insider activity

Insiders reported 87 transactions (2 buys, 30 sells) across 10 reporting insiders, with a net reported value of −$13.7M.

Data flags from SEC filings

Related companies

GENEDX HOLDINGS CORP COM CL A (WGS) · AMNEAL PHARMACEUTICALS INC (AMRX) · NEKTAR THERAPEUTICS (NKTR) · SURGERY PARTNERS INC (SGRY) · RELAY THERAPEUTICS INC (RLAY) · TAKEDA PHARMACEUTICAL CO LTD (TAK)